ME-344

ME-344 is an inhibitor of OXPHOS used in studies of PI3K-Akt-mTOR Signaling and Apoptosis. In practice, this places the compound in experiments that measure growth-factor signaling, survival control, and nutrient-sensing outputs and caspase-associated cell-death signaling and survival decisions in apoptosis, cancer, and metabolism models.

By inhibiting OXPHOS, ME-344 can be used to examine growth-factor signaling, survival control, and nutrient-sensing outputs and caspase-associated cell-death signaling and survival decisions. The signaling pathway modulator annotation adds relevance to pathway-reporter and mechanistic-phenotyping studies, together with downstream-response mapping in the same experimental setting. In apoptosis, cancer, and metabolism models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving OXPHOS
• Pathway perturbation studies connected to PI3K-Akt-mTOR Signaling and Apoptosis
• Concentration-response inhibition and target-dependence studies
• Pathway-reporter and mechanistic-phenotyping studies

Overall, ME-344 is appropriate when a defined chemical perturbant is needed to connect OXPHOS with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in apoptosis, cancer, and metabolism models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.